Research
Print page
Switch language
The Capital Region of Denmark
- a part of Copenhagen University Hospital
Peter Rossing
Chief Consultant
Niels Steensens Vej 2-4
Building: NSK
2820 Gentofte
Denmark
Phone: 30913383
Research areas
Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease
clinical trials, biomarker discovery with targeted and untargeted methods
metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications
Main research areas
Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics
Current research
Focus on late diabetic complications,
biomarkers predicting risk for initiation or progression of complications,
clinical studies of interventions aiming at preventing or treating complications
improving understanding of pathophysiology of complications
Potential conflicts of interest
•consultancy and/or speaking fees (to institution) from AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, MSD, Novo Nordisk and Sanofi Aventis
•research grants from AstraZeneca and Novo Nordisk
shares in Novo Nordisk
ID: 50137657